Mangoceuticals, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
Mangoceuticals, Inc. CEO Jacob D. Cohen increased his beneficial ownership to 14.6% through new stock and option grants, while the company secured a convertible loan and warrants from his controlled trust.
NASDAQ
SCHEDULE 13D/A: Mangoceuticals Insider Jacob Cohen Boosts Stake to 11% Following Significant Stock Bonus
Jacob D. Cohen and The Tiger Cub Trust have updated their beneficial ownership in Mangoceuticals, Inc., with Mr. Cohen receiving a 200,000-share bonus, increasing his aggregate stake to 11.0%.